Clinical efficacy and safety of Ganshuang granules as an adjuvant treatment for chronic hepatitis B liver fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical efficacy and safety of Ganshuang granules as an adjuvant treatment for chronic hepatitis B liver fibrosis

Published:2020-10-09 Issue:41 Volume:99 Page:e22692
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Zeng Shaoqian,Liu Yefang,Jiang Cen,Li Baixue,Wen Li,Feng Quansheng

Funder

Chengdu University of Traditional Chinese Medicine

Department of Science and Technology of Sichuan Province

Chengdu Science and Technology Bureau

Chengdu University of Traditional Chinese Medicine Foundation

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference14 articles.

1. Infection and cancer: the case of hepatitis B;Chan;J Clin Oncol,2016

2. Chronic hepatitis B in Asia-new insights from the past decade;Chan;J Gastroenterol Hepatol,2011

3. Access to treatment for hepatitis b virus infection - worldwide, 2016;Hutin;MMWR Morb Mortal Wkly Rep,2018

4. Hepatitis B virus infection;Yuen;Nat Rev Dis Primers,2018

5. The changing epidemiology of liver diseases in the Asia-Pacific region;Wong;Nat Rev Gastroenterol Hepatol,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naringin from Ganshuang granule inhibits inflammatory to relieve liver fibrosis through TGF-β-Smad signaling pathway;PLOS ONE;2024-06-10

2. Efficacy of Ganshuang granules on non-alcoholic fatty liver and underlying mechanism: a network pharmacology and experimental verification;J TRADIT CHIN MED;2024

3. Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification;Frontiers in Pharmacology;2023-01-24

4. Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease;Frontiers in Pharmacology;2022-12-14

5. Traditional Chinese Medicine Ganshuang Granules Attenuate CCl 4 ‐Induced Hepatic Fibrosis by Modulating Gut Microbiota;Chemistry & Biodiversity;2021-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3